These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37721988)

  • 21. Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.
    Scheidweiler KB; Newmeyer MN; Barnes AJ; Huestis MA
    J Chromatogr A; 2016 Jul; 1453():34-42. PubMed ID: 27236483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of 11 Cannabinoids in Biomass and Extracts of Different Varieties of Cannabis Using High-Performance Liquid Chromatography.
    Gul W; Gul SW; Radwan MM; Wanas AS; Mehmedic Z; Khan II; Sharaf MH; ElSohly MA
    J AOAC Int; 2015; 98(6):1523-8. PubMed ID: 26651563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct Quantitation of Phytocannabinoids by One-Dimensional
    Dadiotis E; Mitsis V; Melliou E; Magiatis P
    Molecules; 2022 May; 27(9):. PubMed ID: 35566314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LC-MS-MS quantification of Δ8-THC, Δ9-THC, THCV isomers and their main metabolites in human plasma.
    Sempio C; Campos-Palomino J; Klawitter J; Harrison A; Peters EN; MacNair L; Haghdoost M; Bonn-Miller M; Babalonis S; Huestis MA; Christians U; Klawitter J
    J Anal Toxicol; 2024 Aug; 48(7):499-506. PubMed ID: 38836589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid β-evoked neurotoxicity and changes in cell morphology in PC12 cells.
    Marsh DT; Sugiyama A; Imai Y; Kato R; Smid SD
    Basic Clin Pharmacol Toxicol; 2024 Mar; 134(3):293-309. PubMed ID: 37697481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat.
    Murphy LL; Steger RW; Smith MS; Bartke A
    Neuroendocrinology; 1990 Oct; 52(4):316-21. PubMed ID: 1979838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of CBD, Δ
    Jaidee W; Siridechakorn I; Nessopa S; Wisuitiprot V; Chaiwangrach N; Ingkaninan K; Waranuch N
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):537-547. PubMed ID: 34096805
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challenge.
    Lee D; Vandrey R; Mendu DR; Anizan S; Milman G; Murray JA; Barnes AJ; Huestis MA
    Clin Chem; 2013 Dec; 59(12):1770-9. PubMed ID: 23938457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and quantification of cannabinoids in postmortem fluids and tissues by liquid chromatography-tandem mass spectrometry.
    Cliburn KD; Huestis MA; Wagner JR; Kemp PM
    J Chromatogr A; 2021 Aug; 1652():462345. PubMed ID: 34198104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking.
    Lee D; Vandrey R; Mendu DR; Murray JA; Barnes AJ; Huestis MA
    Drug Test Anal; 2015 Jun; 7(6):494-501. PubMed ID: 25220020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous Quantification of 13 Cannabinoids and Metabolites in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry in Adult Epilepsy Patients.
    Roslawski MJ; Remmel RP; Karanam A; Leppik IE; Marino SE; Birnbaum AK
    Ther Drug Monit; 2019 Jun; 41(3):357-370. PubMed ID: 30520828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.
    Moore CF; Weerts EM
    Psychopharmacology (Berl); 2022 May; 239(5):1397-1408. PubMed ID: 34652500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Two-Phase, Dose-Ranging, Placebo-Controlled Study of the Safety and Preliminary Test of Acute Effects of Oral Δ
    Peters EN; MacNair L; Harrison A; Feldner MT; Eglit GML; Babalonis S; Turcotte C; Bonn-Miller MO
    Cannabis Cannabinoid Res; 2023 Sep; 8(S1):S71-S82. PubMed ID: 37721990
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetics of Two Nanoemulsion Formulations of Δ
    Tagen M; Klumpers LE; Peshkovsky A
    AAPS PharmSciTech; 2023 Nov; 24(8):239. PubMed ID: 37989959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and Characterization of Impurities in Commercially Marketed Δ
    Radwan MM; Wanas AS; Gul W; Ibrahim EA; ElSohly MA
    J Nat Prod; 2023 Apr; 86(4):822-829. PubMed ID: 36827690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinol (CBN) Cross-Reacts with Two Urine Immunoassays Designed to Detect Tetrahydrocannabinol (THC) Metabolite.
    Kroner GM; Johnson-Davis KL; Doyle K; McMillin GA
    J Appl Lab Med; 2020 May; 5(3):569-574. PubMed ID: 32445358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.
    Goodwin RS; Gustafson RA; Barnes A; Nebro W; Moolchan ET; Huestis MA
    Ther Drug Monit; 2006 Aug; 28(4):545-51. PubMed ID: 16885723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic Strategies for Rare Cannabinoids Derived from
    Nguyen GN; Jordan EN; Kayser O
    J Nat Prod; 2022 Jun; 85(6):1555-1568. PubMed ID: 35648593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
    Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
    Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.